Examination of Risk Factors Affecting the Development of BSI and Mortality in Critically Ill COVID-19 Patients Hospitalized in Intensive Care Unit (ICU): A Single-Center Retrospective Study
Journal of Intensive Care Medicine · 2025
DOI: 10.1177/08850666241305347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Intensive Care Medicine, 2025. Verfasst von Çağla Keskin Sarıtaş und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Marmara University Training and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: COVID-19, Intensive Care Units, Sepsis. Die Arbeit nennt 36 Literaturangaben.
Themen: Intensivpflege
Abstract (Originalsprache)
Background
Various studies have shown that the incidence of BSI is greater in COVID-19 patients hospitalized in the intensive care unit (ICU).
Aims
Our study aimed to determine the risk factors for BSI, mortality rates, and factors affecting mortality in adult COVID-19 patients hospitalized in the ICU.
Methods
All COVID-19 patients who met the study criteria and stayed in intensive care for more than 2 days at a tertiary university hospital during the two-year pandemic period were included in the study. Logistic regression analysis was used to determine the risk factors for BSI and mortality.
Results
We found that respiratory rate (RR) ≥ 30 breaths per minute at the time of admission [OR: 2.342 (95% CI: 1.12-4.897)] and antibiotic use in the month before admission ICU [OR: 3.137 (95% CI: 1.321-7.451)] were independent risk factors for BSI in COVID-19 patients. Subanalysis was also performed according to the doses of immunomodulators such as anakinra, tocilizumab, and corticosteroids, and it was found that they had no effect on the BSI ( P > .05). The predominant causative pathogens were K. pneumoniae , A. baumannii and enterococci. The multidrug resistant rate among bacteria was 78%. Although their comorbidities and disease severity at the time of ICU admission were similar, patients with BSIs had a higher mortality rate (58.1 to 81.9%, P = .000). The SAPS-2 score at ICU admission [OR: 3.095 (95% CI: 1.969-4.865)] and mechanical ventilation requirement throughout the ICU admission [OR: 9.314 (95% CI: 3.878-22.37)] were found to be independent risk factors for mortality by multivariate analysis. BSI was not found to be a risk factor for mortality (> .05).
Conclusions
Antibiotic use in patients with severe COVID-19 significantly increases the risk of BSI; unnecessary antibiotic use should be avoided.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Marmara University Training and Research Hospital, Istanbul, Turkey.
- Department of Infectious Diseases and Clinical Microbiology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.
ORCID-Profile: Çağla Keskin Sarıtaş
Zitieren
APA
Keskin Sarıtaş, Ç., Özsüt, H., Benli, A., & Başaran, S. (2025). Examination of Risk Factors Affecting the Development of BSI and Mortality in Critically Ill COVID-19 Patients Hospitalized in Intensive Care Unit (ICU): A Single-Center Retrospective Study. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666241305347
Vancouver
Keskin Sarıtaş Ç, Özsüt H, Benli A, Başaran S. Examination of Risk Factors Affecting the Development of BSI and Mortality in Critically Ill COVID-19 Patients Hospitalized in Intensive Care Unit (ICU): A Single-Center Retrospective Study. Journal of Intensive Care Medicine. 2025. doi:10.1177/08850666241305347
BibTeX
@article{KeskinSarta2025,
author = {Keskin Sarıtaş, Çağla and Özsüt, Halit and Benli, Aysun and Başaran, Seniha},
title = {Examination of Risk Factors Affecting the Development of BSI and Mortality in Critically Ill COVID-19 Patients Hospitalized in Intensive Care Unit (ICU): A Single-Center Retrospective Study},
journal = {Journal of Intensive Care Medicine},
year = {2025},
doi = {10.1177/08850666241305347}
}
EUVIMED